HemaSphere
(Jun 2022)
P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA
- N. Mochkin,
- V. Sarzhevskiy,
- Y. Protopopova,
- E. Demina,
- V. Melnichenko,
- V. Bogatyrev,
- A. Samoylova,
- A. Mamedova,
- A. Rukavitsyn,
- A. Bannikova,
- E. Smirnova,
- N. Shorokhov
Affiliations
- N. Mochkin
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- V. Sarzhevskiy
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- Y. Protopopova
- 2 I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
- E. Demina
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- V. Melnichenko
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- V. Bogatyrev
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- A. Samoylova
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- A. Mamedova
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- A. Rukavitsyn
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- A. Bannikova
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- E. Smirnova
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- N. Shorokhov
- 1 FSBI National Medical Surgical Center n.a. N.I. Pirogov
- DOI
-
https://doi.org/10.1097/01.HS9.0000847232.50505.64
- Journal volume & issue
-
Vol. 6
pp.
981
– 982
WeChat QR code